In-Person US FDA Meetings Returning? Agency Will Support Those Events At HQ

 
• By Derrick Gingery
FDA biosimilar workshop panel discussion
The audience was virtual, but many FDA speakers attended the biosimilars workshop in person. • Source: Screenshot of FDA broadcast

More from US FDA

More from Agency Leadership